| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/17/2002 | US20020006637 Particle-mediated transformation of animal tissue cells |
| 01/17/2002 | US20020006630 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers |
| 01/17/2002 | US20020006610 Detection of enterovirus in a sample; provide sample, inoculate sample, monitor sample for presence of enterovirus |
| 01/17/2002 | US20020006607 Soild supports for use in monitoring osteogenesis |
| 01/17/2002 | US20020006428 Scaffold comprising biodegradable, biocompatible, porous matrix including a polyesterether copolymer such as a polyethylene gycol-polybutylene terephthalate copolymer |
| 01/17/2002 | US20020006408 Vaccines against eimeria mediated disorder |
| 01/17/2002 | US20020006398 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 01/17/2002 | US20020006397 Delivering a cytotoxic agent which is one or more of herpes simplex virus thymidine kinase (HSV-tk), gancicolvir, or a rejection antigen, into a antigenic biniding protein APBP molecule to induce lysis of target cell |
| 01/17/2002 | US20020006392 Isolating peripheral mononuclear blood cells from a recipient and a donor; mixing donor and recipient cells ex vivo, treating the cells with a regulatory composition (TGF-beta) transforming growth factor to activate the cells |
| 01/17/2002 | US20020006379 Diagnosis of tissue damage, cancer |
| 01/17/2002 | US20020005205 Joint repair using mesenchymal stem cells |
| 01/17/2002 | CA2658217A1 Expression system |
| 01/17/2002 | CA2416219A1 Artificial antibody polypeptides |
| 01/17/2002 | CA2416203A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants |
| 01/17/2002 | CA2415808A1 Transporters and ion channels |
| 01/17/2002 | CA2415767A1 High fidelity polymerases and uses thereof |
| 01/17/2002 | CA2415763A1 Production of chimeric human papillomavirus |
| 01/17/2002 | CA2415544A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/17/2002 | CA2415484A1 Human myeloma cell line |
| 01/17/2002 | CA2415483A1 Antisense compositions targeted to .beta.1 adrenoceptor-specific mrna and methods of use |
| 01/17/2002 | CA2415434A1 Use of the heat shock protein gp96 |
| 01/17/2002 | CA2415422A1 Chromosome 3p21.3 genes are tumor suppressors |
| 01/17/2002 | CA2415382A1 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target |
| 01/17/2002 | CA2415350A1 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
| 01/17/2002 | CA2415127A1 Down syndrome critical region 1-like 1 proteins |
| 01/17/2002 | CA2414510A1 Use of bioactive glass compositions to stimulate osteoblast production |
| 01/17/2002 | CA2414495A1 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 01/17/2002 | CA2414460A1 Fimh adhesin proteins and methods of use |
| 01/17/2002 | CA2414387A1 Drug metabolizing enzymes |
| 01/17/2002 | CA2414374A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/17/2002 | CA2414219A1 Lipid metabolism molecules |
| 01/17/2002 | CA2413810A1 Aminoacyl trna synthetases |
| 01/17/2002 | CA2413045A1 Expression system |
| 01/17/2002 | CA2412764A1 Stimulation of cellular regeneration and differentiation in the inner ear |
| 01/17/2002 | CA2412581A1 Transforming growth factor beta (tgf-.beta.) blocking agent-treated stem cell composition and method |
| 01/17/2002 | CA2351110A1 Helicobacter felis vaccine |
| 01/16/2002 | EP1172441A1 A promoter derived from phytosulfokine precursor gene |
| 01/16/2002 | EP1172438A1 Polyhyroxyalkanoate synthase and gene encoding the same enzyme |
| 01/16/2002 | EP1171626A1 50 human secreted proteins |
| 01/16/2002 | EP1171621A1 Plant transformation method |
| 01/16/2002 | EP1171620A1 Acquired resistance genes in plants |
| 01/16/2002 | EP1171616A1 Method for enhancing myoblast migration and invasion in the context of gene therapy |
| 01/16/2002 | EP1171615A2 Cell culture process for glycoproteins |
| 01/16/2002 | EP1171614A1 Dsp-4 dual-specificity map kinase phosphatase |
| 01/16/2002 | EP1171613A1 Dsp-7 dual-specificity map kinase phosphatase |
| 01/16/2002 | EP1171612A2 Telomerase-specific cancer vaccine |
| 01/16/2002 | EP1171610A1 Nucleic acid sequences to proteins involved in isoprenoid synthesis |
| 01/16/2002 | EP1171609A2 Lipoxygenase proteins and polynucleotides encoding the same |
| 01/16/2002 | EP1171602A1 Anti-angiogenic intestinal peptides, zdint5 |
| 01/16/2002 | EP1171600A2 Zalpha13: a human secreted protein |
| 01/16/2002 | EP1171599A1 Adipocyte complement related protein homolog zacrp2 |
| 01/16/2002 | EP1171596A1 Synthetic transmembrane components |
| 01/16/2002 | EP1171595A1 13 transmembrane protein expressed in prostate cancer |
| 01/16/2002 | EP1171594A1 Vascular endothelial cell growth factor variants and uses thereof |
| 01/16/2002 | EP1171591A1 48 human secreted proteins |
| 01/16/2002 | EP1171590A1 50 human secreted proteins |
| 01/16/2002 | EP1171589A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof |
| 01/16/2002 | EP1171588A1 P element derived vector and methods for its use |
| 01/16/2002 | EP1171585A1 49 human secreted proteins |
| 01/16/2002 | EP1171581A1 Lipase variant |
| 01/16/2002 | EP1171580A2 Human homologues of fused gene |
| 01/16/2002 | EP1171579A1 Human tumor necrosis factor receptor tr9 |
| 01/16/2002 | EP1171578A2 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof |
| 01/16/2002 | EP1171577A2 Anti-bacterial vaccine compositions |
| 01/16/2002 | EP1171573A1 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 01/16/2002 | EP1171572A2 Modular cell carrier systems for the three-dimensional cell growth |
| 01/16/2002 | EP1171470A1 Antibodies to placental protein 13 |
| 01/16/2002 | EP1171469A1 ANTI-p53 ANTIBODIES |
| 01/16/2002 | EP1171462A2 49 human secreted proteins |
| 01/16/2002 | EP1171460A1 48 human secreted proteins |
| 01/16/2002 | EP1171458A1 50 human secreted proteins |
| 01/16/2002 | EP1171457A1 46 human secreted proteins |
| 01/16/2002 | EP1171456A1 50 human secreted proteins |
| 01/16/2002 | EP1171165A1 Intramyocardial injection of autologous bone marrow |
| 01/16/2002 | EP1171157A2 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 01/16/2002 | EP1171057A1 Cell-culture and polymer constructs |
| 01/16/2002 | EP1171006A1 Functionalized poly(propylene fumarate) and poly(propylene fumarate-co-ethylene glycol) |
| 01/16/2002 | EP1170993A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1 |
| 01/16/2002 | EP0817859B1 Recombinant dna vectors for gene therapy |
| 01/16/2002 | EP0786088B1 Presentation of lipoarabinomannan antigens to t-cells by cd1 molecules |
| 01/16/2002 | EP0697875B1 Use of modified tall-104 cells to treat cancer and viral diseases |
| 01/16/2002 | EP0496875B1 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA |
| 01/16/2002 | CN1331747A Transgenic plants comprising counditionally lethal gene and its prodn. method |
| 01/16/2002 | CN1331746A Regulatory sequences useful for gene expression in plant embryo tissue |
| 01/16/2002 | CN1331742A Lipolytic enzyme varints |
| 01/16/2002 | CN1331700A Generation of antibodies using polynucleotide vaccination in avian species |
| 01/16/2002 | CN1331699A Methods of identifying antigen gene sequences |
| 01/16/2002 | CN1331558A Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 01/16/2002 | CN1077919C Recombinant DNA viral vector for transfecting animal cells |
| 01/15/2002 | US6339183 A vector containing a promoter linked to a heterologous gene that directs expression into the urogenital epithelium of transgenic animals, turning the bladder into a bioreactor; for recovering biologically active molecules from urine |
| 01/15/2002 | US6339151 Forming compounds using a nucleic acid base with a phosphorous halide to form drugs for nonproliferation of cells |
| 01/15/2002 | US6339149 Isolated nucleic acid molecules which encode tumor rejection antigens found in dage |
| 01/15/2002 | US6339140 SSX family proteins |
| 01/15/2002 | US6339060 For therapy of infections caused by microorganisms |
| 01/15/2002 | US6338964 Cell culture mrdium with buffer of aminosulfonic acid molecule and metal complexing agent |
| 01/15/2002 | US6338963 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 01/15/2002 | US6338961 Isolated DNA sequence capable of serving as regulatory element in a chimeric gene which can be used for the transformation of plants |
| 01/15/2002 | US6338953 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein |
| 01/15/2002 | US6338950 DNA encoding LST-1 protein and process for recombinant production of LST-1 protein |
| 01/15/2002 | US6338944 Methods for measuring stromelysin-1 promoter activity |